Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Lipoprotein glomerulopathy.

Tsimihodimos V, Elisaf M.

Curr Opin Lipidol. 2011 Aug;22(4):262-9. doi: 10.1097/MOL.0b013e328345ebb0. Review.

PMID:
21464714
2.

A rare cause of nephrotic syndrome: lipoprotein glomerulopathy.

Cheung CY, Chan AO, Chan YH, Lee KC, Chan GP, Lau GT, Shek CC, Chau KF, Li CS.

Hong Kong Med J. 2009 Feb;15(1):57-60.

3.

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.

Bomback AS, Song H, D'Agati VD, Cohen SD, Neal A, Appel GB, Rovin BH.

Nephrol Dial Transplant. 2010 Oct;25(10):3442-6. doi: 10.1093/ndt/gfq389. Epub 2010 Jul 11.

4.

Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.

Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P, Albertazzi A.

J Med Case Rep. 2009 Dec 2;3:9311. doi: 10.1186/1752-1947-3-9311.

5.

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.

Saito T, Ishigaki Y, Oikawa S, Yamamoto TT.

Trends Cardiovasc Med. 2002 Feb;12(2):67-70. Review.

PMID:
11852253
6.

Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature.

Saito T, Sato H, Oikawa S, Kudo K, Kurihara I, Nakayama K, Abe K, Yoshinaga K, Sakaguchi H.

Am J Nephrol. 1993;13(1):64-8. Review.

PMID:
8322843
7.

Lipoprotein glomerulopathy in China.

Chen Y.

Clin Exp Nephrol. 2014 Apr;18(2):218-9. doi: 10.1007/s10157-013-0873-x. Epub 2013 Oct 29. Review.

PMID:
24165683
8.

Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e.

Magistroni R, Bertolotti M, Furci L, Fano RA, Leonelli M, Pisciotta L, Pellegrini E, Calabresi L, Bertolini S, Calandra S.

Clin Med Insights Case Rep. 2013 Dec 5;6:189-96. doi: 10.4137/CCRep.S12209. eCollection 2013.

9.

Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.

Hoffmann M, Scharnagl H, Panagiotou E, Banghard W, Wieland H, März W.

J Am Soc Nephrol. 2001 Mar;12(3):524-30.

10.

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Saito T, Matsunaga A, Oikawa S.

Am J Kidney Dis. 2006 Feb;47(2):199-211. Review.

PMID:
16431249
11.

Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.

Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS.

Chin Med J (Engl). 2005 Apr 5;118(7):555-60.

PMID:
15820086
12.

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.

Saito T, Oikawa S, Sato H, Sato T, Ito S, Sasaki J.

Kidney Int Suppl. 1999 Jul;71:S37-41.

PMID:
10412734
13.

Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China.

Han J, Pan Y, Chen Y, Li X, Xing G, Shi J, Hou P, Zhang H, Wang H.

Nephron Clin Pract. 2010;114(4):c260-7. doi: 10.1159/000276578. Epub 2010 Jan 20.

PMID:
20090368
14.

A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.

Boumendjel R, Papari M, Gonzalez M.

Arch Pathol Lab Med. 2010 Feb;134(2):279-82. doi: 10.1043/1543-2165-134.2.279.

PMID:
20121619
15.

The role of apolipoprotein E genetic variants in lipoprotein disorders.

Rall SC Jr, Mahley RW.

J Intern Med. 1992 Jun;231(6):653-9. Review.

PMID:
1619388
16.

Hyperlipidemia of nephrosis: pathophysiologic role in progressive glomerular disease.

Diamond JR.

Am J Med. 1989 Nov;87(5N):25N-29N. Review.

PMID:
2486541
17.

Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.

Luo B, Huang F, Liu Q, Li X, Chen W, Zhou SF, Yu X.

Am J Nephrol. 2008;28(2):347-53. Epub 2007 Nov 29.

18.

Abnormal lipid metabolism and renal disorders.

Saito T.

Tohoku J Exp Med. 1997 Mar;181(3):321-37. Review.

19.

Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.

de Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM.

Hum Mutat. 1994;4(3):178-94. Review.

PMID:
7833947
20.

Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Hamatani H, Hiromura K, Kobatake K, Yoshida H, Kobayashi S, Yoneda N, Kayakabe K, Matsumoto T, Kuroiwa T, Ueki K, Nojima Y.

Clin Exp Nephrol. 2010 Dec;14(6):619-24. doi: 10.1007/s10157-010-0333-9. Epub 2010 Sep 15.

PMID:
20842518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk